期刊文献+

浅析《国家基本药物目录》中中成药的辨证应用 被引量:1

Application of Chinese Patent Medicine in Essential Drugs List
原文传递
导出
摘要 目的:为辨证应用《国家基本药物目录·基层医疗卫生机构配备使用部分》(2009版)中的中成药提供参考。方法:通过分析102种中成药的功能主治和主要成分,按阴阳、表里、虚实、寒热、升降沉浮、归经等中医药的辨证论治思想进行分析。结果与结论:中医药以辨证论治为诊疗特点,临床应用中成药时,应注意辨析其适应证,严格按照说明书的用法用量使用,并密切观察不良反应的发生。 OBJECTIVE: To explore the application of Chinese patent medicine in National Essential Drugs List. METHODS: The main function and component of 102 kinds of Chinese patent medicine in National Essential Drugs List were analyzed accord- ing to the treatment theory based on differentiation of symptom-complex, such as yin-yang, exterior and interior, deficiency and ex- cess, chills and fever, ascending, descending, sinking and floating, channel tropism. RESULTS & CONCLUSION: The applica- tion of Chinese patent medicine should be in line with package insert. Dosage and usage and the occurrence of ADR should be paid attention and observed. The philosophical characteristics of treatment theory based on differentiation of symptom-complex can be re- flected by identifying yin-yang, exterior and interior, deficiency and excess, chills and fever, ascending, descending, sinking and floating, channel tropism
作者 郭志军
出处 《中国药房》 CAS CSCD 北大核心 2011年第8期729-731,共3页 China Pharmacy
关键词 国家基本药物目录 中成药 辨证 National Essential Drugs List Chinese patent medicine Treatment based on differentiation of symptom-complex
  • 相关文献

参考文献1

二级参考文献23

  • 1张卫华.三种木通利尿作用及其毒性的比较研究[J].中国药学杂志,1989,24(10):594-596. 被引量:46
  • 2杨秀伟.药学前沿(2003年卷).北京:中国医药科技出版社,2004:396-447
  • 3Zhou S,Koh H L,Gao Y,et al.Herbal bioactivation:The good,the bad and the ugly.Life Sci,2004,74 (8):935 -968
  • 4Gardner I,Wakazono H,Bergin P,et al.Cytochrome P450 mediated bioactivation of methyleugenol to 1 '-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.Carcinogenesis,1997,18 (9):1775-1783
  • 5Johnson J D,Ryan M J,Toft J D I I,et al.Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F(1) mice.J Agric Food Chem,2000,48 (8):3620-3632
  • 6National Toxicology Program.NTP Toxicology and carcinogenesis studies of methyleugenol (CAS NO.93-15-2) in F344/N Rats and B6C3F1 mice (Gavage Studies).Natl Toxicol Program Tech Rep Ser,2000,491:1-412
  • 7Chan V S,Caldwell J.Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.Food Chem Toxicol,1992,30 (10):831-836
  • 8Gardner I,Bergin P,Stening P,et al.Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.Chem Res Toxicol,1996,9(4):713-721
  • 9Schecter A,Lucier G W,Cunningham M L,et al.Human consumption of methyleugenol and its elimination from serum.Environ Health Perspect,2004,112 (6):678-680
  • 10Hong C B,Chung M S,Yang C H,et al.Gardenia poisoning in guinea pigs.J Chin Soc Vet Sci,1976,2 (1):26-29

共引文献33

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部